Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
YIC-C8-434 is an inhibitor of acyl-CoA:cholesterol acyltransferase (ACAT; IC50 = 11 nM in isolated rat hepatic microsomes).1 It reduces plasma cholesterol levels by 79% in rats when administered at a dose of 0.005% in a high-cholesterol diet. Oral administration of YIC-C8-434 (8.3 mg/kg per day) reduces cholesterol absorption by the small intestine by 17% in rats.2 YIC-C8-434 is primarily metabolized by the cytochrome P450 (CYP) isoform CYP3A2, which is expressed at lower levels in the female rat liver, and is selectively toxic to female rats, where it reduces food intake, weight gain, and organ weights.3
WARNING This product is not for human or veterinary use.
1. Structure-
2. Inhibitory effects of N-
3. Sex-